Here are all the important point notes from your PDF — simple, crisp, exam-ready:
📝 HORMONES PHARMACOLOGY — IMPORTANT POINT NOTES
MUHS 2nd Year MBBS
🔵 TOPIC 1: THYROID HORMONES
Hormones of thyroid gland: T3, T4, Calcitonin
Synthesis Steps — Remember: TOIHR
- T — Trapping (iodide taken into follicular cells via NIS — sodium/iodide symporter)
- O — Oxidation (iodide → iodine by peroxidase)
- I — Iodination (iodine + tyrosine → MIT and DIT)
- H — Hormone formation / Coupling (MIT+DIT = T3 / DIT+DIT = T4) — by thyroid peroxidase
- R — Release (controlled by TSH; endocytosis + proteolysis of thyroglobulin)
Key points:
- Most hormone released from thyroid is T4 (less potent)
- T4 → T3 conversion occurs in liver and kidney
- T3 is more potent than T4
🔵 TOPIC 2: ANTITHYROID DRUGS
Classification (easy):
- Block synthesis → Thioamides (PTU, Methimazole, Carbimazole)
- Block iodide trapping → Ionic inhibitors (Thiocyanate, Perchlorate, Nitrate)
- Block hormone release → Iodine/Iodides (Lugol's iodine, KI)
- Destroy thyroid tissue → Radioactive iodine (¹³¹I)
A) THIOAMIDES — PTU, Methimazole, Carbimazole
3 actions (all block thyroid peroxidase):
- Iodide → Iodine conversion blocked
- Iodination of tyrosine blocked
- Coupling of MIT + DIT blocked
Extra action of PTU only:
- Also blocks peripheral T4 → T3 conversion (that's why PTU used in thyroid storm)
Pharmacokinetics — key points:
- All well absorbed orally
- Carbimazole is a prodrug → converted to methimazole in body
- Accumulate in thyroid gland
Adverse effects:
- Skin rashes — most common
- Agranulocytosis — rare but dangerous
- Joint pain, fever, hepatitis, nephritis
Uses — 4 important:
- Long-term hyperthyroidism (Graves' disease, toxic nodular goitre)
- Preoperatively before thyroidectomy → to make patient euthyroid
- With radioactive iodine → for initial control (¹³¹I is slow)
- Thyroid storm (PTU preferred)
Which one to prefer?
- Carbimazole/Methimazole preferred for long-term → long acting, not hepatotoxic
- PTU preferred in thyroid storm and pregnancy (crosses placenta less)
B) IODINE AND IODIDES
Key points:
- Oldest antithyroid agents
- Most rapid acting antithyroid drugs
- Preparations: Lugol's iodine (5% iodine + 10% KI), Ipodate sodium, Iopanoic acid
Uses:
- Preoperatively before thyroidectomy (makes gland firm, small, less vascular → less bleeding during surgery)
- Thyroid storm
- KI as expectorant (mucolytic)
- Tincture of iodine as antiseptic
- Iodized salt → prophylaxis of endemic goitre
Adverse effects:
- Type III hypersensitivity → angioedema, laryngeal oedema, arthralgia, fever, eosinophilia
C) RADIOACTIVE IODINE (¹³¹I)
- ¹³¹I half-life = 8 days → therapeutic use
- ¹²³I half-life = 13 hours → diagnostic scan
Uses:
- Hyperthyroidism (Graves' disease, toxic nodular goitre) — especially elderly + cardiac patients
- Adenoma/carcinoma when surgery not feasible
Contraindications: Pregnancy, children, nursing mothers
Advantages: Outpatient, cheap, no surgery, permanent cure
Disadvantages: Slow acting, high incidence of hypothyroidism, soreness in neck
🔵 TOPIC 3: THYROID STORM (THYROID CRISIS)
What is it? Severe hypermetabolic state due to very high thyroid hormones in blood
Features = usual hyperthyroidism + extra 4:
- Hyperpyrexia (very high fever)
- Cardiac arrhythmias (atrial fibrillation)
- Nausea, vomiting, diarrhoea
- Mental confusion / coma
Precipitating factors: Infection, trauma, surgery, DKA, MI
Treatment (6 steps):
- Hospitalization + supportive care (cooling, hydration, sedation, antibiotics)
- Propranolol IV 1-2 mg every 4 hours → controls tachycardia, tremors; blocks T4→T3 conversion
- PTU via nasogastric tube → blocks synthesis + T4→T3 conversion
- Sodium ipodate 0.5 g orally → blocks hormone release + T4→T3 conversion
- Diltiazem → if propranolol is contraindicated
- Hydrocortisone 100 mg IV every 8 hrs → blocks T4→T3; corrects adrenal insufficiency
🔵 TOPIC 4: INSULIN
Basic Facts:
- Made by β-cells of pancreatic islets
- Route: preproinsulin → proinsulin → insulin (C-peptide removed)
- Structure: A chain + B chain connected by 2 disulphide bridges
Actions:
- ↑ glucose uptake, glycogen synthesis, protein synthesis, lipogenesis
- ↓ gluconeogenesis, glycogenolysis, lipolysis, ketogenesis
Mechanism of Action:
- Receptor = Tyrosine kinase receptor (2α + 2β subunits)
- α subunit = extracellular (binds insulin)
- β subunit = transmembrane with tyrosine kinase activity
- Binding → tyrosine kinase activation → phosphorylation cascade → glucose enters cell
Pharmacokinetics:
- Destroyed in gut → NOT oral
- Route: SC (subcutaneous) usually; IV only in emergencies (regular insulin)
- Half-life after IV = ~6 minutes (liver + kidney metabolize)
Insulin Preparations (by duration):
| Type | Example | Onset | Peak | Duration |
|---|
| Rapid-acting | Lispro, Aspart, Glulisine | 5-15 min | 1 hr | 3-4 hr |
| Short-acting | Regular (Soluble) | 30 min | 2-3 hr | 6-8 hr |
| Intermediate | NPH | 1-2 hr | 4-8 hr | 12-18 hr |
| Long-acting | Glargine, Detemir | 1-2 hr | No peak | 20-24 hr |
Memory: Rapid-lag, Short-soluble, Long-gaal
Concentrations: 40 U/mL or 100 U/mL; Regular also in 500 U/mL
Indications:
- Type 1 DM (all patients, always)
- DKA
- Non-ketotic hyperglycaemic coma
- Diabetes in pregnancy
- Stress (surgery, infection, trauma) in diabetics
- Type 2 DM when oral drugs fail
Site of Injection (SC): Abdomen, buttock, anterior thigh, dorsal arm
Complications:
| Complication | Key point |
|---|
| Hypoglycaemia | Most common + most dangerous; prolonged → brain damage |
| Allergic reactions | Local skin reactions; rare |
| Lipodystrophy | Atrophy/hypertrophy at site; prevent by rotating injection sites |
| Oedema | Salt and water retention |
🔵 TOPIC 5: DIABETIC KETOACIDOSIS (DKA)
Occurs in: Type 1 DM (rare in Type 2)
Precipitants: Infection, trauma, severe stress
Features:
- Anorexia, nausea, vomiting
- Polyuria, abdominal pain
- Hypotension, tachycardia
- Kussmaul breathing (hyperventilation)
- Altered consciousness → coma
Management — 6 steps:
-
Insulin — Regular insulin IV bolus 0.2–0.3 U/kg → then 0.1 U/kg/hr infusion
- Blood glucose should ↓ by 10% in first hour
- Once conscious → shift to SC insulin
-
Fluids — Normal saline 1 L/hr → reduce gradually
- When blood glucose reaches ~250 mg/dL → switch to 5% dextrose + normal saline (prevents hypoglycaemia + cerebral oedema)
-
Potassium — After insulin, K⁺ shifts into cells → hypokalaemia
- Give KCl 10–20 mEq/hr after 4 hours of insulin
- Monitor serum K⁺ and ECG
-
Sodium bicarbonate — IV if severe acidosis
-
Phosphate — If severe hypophosphataemia
-
Antibiotics — For associated infection
🔵 TOPIC 6: ORAL ANTIDIABETIC DRUGS
Classification (Simple):
| Class | Drugs | Action |
|---|
| Sulphonylureas | Tolbutamide, Glibenclamide, Glipizide, Gliclazide, Glimepiride | ↑ insulin secretion |
| Biguanides | Metformin | ↓ gluconeogenesis, ↑ insulin sensitivity |
| Thiazolidinediones | Pioglitazone | ↑ insulin sensitivity |
| α-Glucosidase inhibitors | Acarbose, Miglitol, Voglibose | ↓ carbohydrate absorption |
| Meglitinides | Repaglinide, Nateglinide | ↑ insulin secretion |
| DPP-4 inhibitors | Sitagliptin, Vildagliptin, Linagliptin | ↑ incretin effect |
| SGLT-2 inhibitors | Dapagliflozin | ↑ glucose excretion in urine |
A) SULPHONYLUREAS
Mechanism: Block K⁺-ATP channels in β-cells → depolarization → Ca²⁺ influx → insulin secretion (insulin secretagogue)
Adverse effects — 5 important:
- Hypoglycaemia — MC complication (especially glibenclamide, chlorpropamide — long acting); avoid glibenclamide in elderly
- GI disturbances (nausea, vomiting, flatulence)
- Weight gain
- Skin rashes, photosensitivity
- Teratogenic — NOT safe in pregnancy
Use: Type 2 DM only
B) METFORMIN (Biguanide)
Mechanism — 3 actions:
- Activates AMPK → ↓ hepatic gluconeogenesis (main action)
- ↑ peripheral glucose utilization in muscle and fat
- ↓ intestinal absorption of glucose
- Does NOT stimulate insulin secretion → improves insulin sensitivity
Adverse effects:
- Metallic taste, nausea, vomiting, diarrhoea, weight loss
- Lactic acidosis — most serious (rare)
- Vitamin B12 deficiency — on prolonged use (malabsorption)
- Does NOT cause hypoglycaemia ✅
Key advantages:
- Drug of choice in obese Type 2 DM
- Protects against vascular complications
- No hypoglycaemia
C) PIOGLITAZONE (Thiazolidinedione)
Mechanism: Activates PPAR-γ → ↑ insulin sensitivity in tissues
Adverse effects: Oedema, weight gain, anaemia, heart failure, hepatotoxicity (rare), bladder cancer (rare)
D) ACARBOSE (α-Glucosidase inhibitor)
Mechanism: Blocks α-glucosidase enzyme in small intestine brush border → ↓ carbohydrate digestion → ↓ postprandial hyperglycaemia
Key points:
- Must be taken just before food
- Best for obese Type 2 DM patients
- Side effects: flatulence, fullness, diarrhoea (all GI — because undigested carbs ferment in colon)
🔵 TOPIC 7: CORTICOSTEROIDS
Classification:
- Short acting: Hydrocortisone (Cortisol)
- Intermediate acting: Prednisolone, Methylprednisolone, Triamcinolone, Deflazacort
- Long acting: Dexamethasone, Betamethasone
- Mineralocorticoids: Aldosterone, Fludrocortisone, DOCA
Pharmacological Actions:
1. Carbohydrate → ↑ glycogen in liver, ↑ gluconeogenesis, ↓ peripheral glucose use → hyperglycaemia
2. Fat → Redistribution → Moon face, buffalo hump, fish mouth, thin limbs (Cushing's look)
3. Protein → Catabolic → breakdown of muscle, bone, skin → muscle wasting, thin skin, osteoporosis, growth retardation, poor wound healing
4. Electrolytes → Na⁺ + water retention, K⁺ loss → oedema, hypertension
- Dexamethasone, betamethasone, triamcinolone → NO Na⁺ retention
5. Calcium → Anti-Vitamin D effect → ↓ Ca²⁺ absorption, ↑ renal excretion, ↑ osteoclast activity → osteoporosis, pathological fractures
6. CVS → Na⁺ retention → hypertension; permissive effect on adrenaline/angiotensin
7. Muscle → Required for normal function; weakness in both hypo and hypercorticism
8. GIT → Inhibit PGs → ↑ gastric acid + pepsin → aggravate peptic ulcer
9. Anti-inflammatory → Via lipocortin → inhibit phospholipase A₂ → ↓ arachidonic acid → ↓ PGs + LTs
Adverse Effects — Remember "COME BUGS":
- C — Cushing's (moon face, buffalo hump)
- O — Osteoporosis + fractures
- M — Muscle weakness, myopathy
- E — Electrolyte changes (Na⁺↑, K⁺↓), oedema
- B — Blood sugar ↑ (diabetes aggravated)
- U — Ulcer (peptic)
- G — Growth retardation in children; Glaucoma + cataract
- S — Suppression of immunity → infections (TB reactivation, candidiasis, herpes)
(Also: CNS effects — insomnia, mood changes, psychosis)
Therapeutic Uses — All 14:
- Rheumatoid arthritis — symptomatic relief (doesn't stop progression)
- Osteoarthritis — intra-articular injection
- Rheumatic fever with carditis + CCF
- Gout — reserve drug (when NSAIDs fail)
- Allergic diseases — hay fever, urticaria, angioedema, anaphylaxis
- Bronchial asthma — IV hydrocortisone (acute); inhaled beclomethasone/budesonide (chronic)
- Collagen diseases — polymyositis, polyarteritis nodosa, dermatomyositis
- Nephrotic syndrome — first-line drug
- Ocular diseases — topical/subconjunctival/systemic
- Skin diseases — topical preferred
- Haematological — autoimmune haemolytic anaemia; lymphomas, leukaemia, Hodgkin's, myeloma
- Cerebral oedema — very effective for brain tumours, metastasis, TB meningitis; least effective in head injury
- Ulcerative colitis — methylprednisolone retention enema
- Septic shock — prompt IV glucocorticoids may be life-saving
🔵 TOPIC 8: HORMONAL CONTRACEPTIVES
Types:
- Combined pill (Oestrogen + Progestin)
- Mini pill (Progestin only)
- Emergency/Postcoital pill
- Injectable
Combined Pill — Schedule:
- 1 tablet daily for 21 days → 7-day gap → repeat
- Efficacy: 98–99.9%
Mini Pill — Schedule:
- 1 tablet daily continuously (no gap)
- Efficacy: 96%
Mechanism of Combined Pill — 4 ways:
- ↓ FSH + LH by negative feedback on hypothalamus-pituitary → no ovulation (main action)
- Tubal + uterine contractions → interfere with fertilization
- Endometrium made unsuitable for implantation
- Progestin → thick cervical mucus → blocks sperm penetration
Emergency Contraception (Morning After Pill):
- Used within 72 hours of unprotected intercourse
- Levonorgestrel 0.75 mg × 2 doses (most common)
- Mifepristone 600 mg single dose (antiprogestin)
- Ulipristal — can be used up to 120 hours
- Mechanism: interferes with implantation + anti-ovulatory
Beneficial Effects:
Contraceptive: Prevents unwanted pregnancy
Non-contraceptive:
- ↓ Dysmenorrhoea + premenstrual tension
- ↓ Iron deficiency anaemia (less menstrual loss)
- ↓ Pelvic inflammatory disease + endometriosis
- ↓ Risk of ovarian and endometrial cancer ✅
Adverse Effects:
- Early: Nausea, vomiting, headache, breakthrough bleeding
- Late: Weight gain, fluid retention, acne, skin pigmentation, BP ↑
- Serious (long-term): Venous thromboembolism (especially smokers), risk of MI + stroke (in diabetes/hypertension), gallstones, breast cancer, benign liver tumours
- Impaired glucose tolerance (rare with low-dose)
Injectable Contraceptives:
| Drug | Dose + Frequency |
|---|
| DMPA (Depot medroxyprogesterone acetate) | 150 mg IM every 3 months |
| NET-EN (Norethindrone enanthate) | 200 mg IM every 2 months |
Advantages: No daily pill, safe during lactation, ↓ endometrial cancer
Disadvantages: Menstrual irregularities, headache, mood changes, weight gain, osteoporosis, ↓HDL/↑LDL, fertility returns after 6–8 months delay
🔵 TOPIC 9: UTERINE RELAXANTS (TOCOLYTICS)
Definition: Drugs that relax uterus and delay/stop premature labour
Classification:
- β₂-agonists: Ritodrine, Salbutamol, Terbutaline, Isoxsuprine
- Calcium channel blockers: Nifedipine
- Oxytocin antagonist: Atosiban
- Others: Magnesium sulfate, Progesterone, Nitrates, Halothane
Uses:
- Preterm labour — to delay it
- Threatened abortion
- Dysmenorrhoea
β₂-agonists — Key Points:
- Adverse effects: Tachycardia, palpitations, arrhythmias, pulmonary oedema, hyperglycaemia, hypokalaemia
- Avoid in: Pregnant women with diabetes or heart disease
NSAIDs (Indomethacin) as tocolytic:
- Blocks PG synthesis → uterine relaxation
- NOT used for preterm labour → risk of premature closure of ductus arteriosus → pulmonary hypertension
- OK for dysmenorrhoea only
🔵 TOPIC 10: UTERINE STIMULANTS (OXYTOCICS)
Classification:
- Posterior pituitary: Oxytocin, Desamino-oxytocin
- Ergot alkaloids: Ergometrine, Methylergometrine
- Prostaglandins: PGE₂ (Dinoprostone), PGF₂α (Dinoprost), Carboprost (15-methyl PGF₂α), Misoprostol
- Others: Ethacridine, Quinine
OXYTOCIN — Most Important
Where is it made? Hypothalamus → stored in neurohypophysis (posterior pituitary)
Actions on 4 organs:
| Organ | Effect |
|---|
| Uterus | Contracts pregnant uterus; sensitivity ↑ by oestrogen, ↓ by progesterone |
| Breast | Contracts myoepithelial cells → milk ejection |
| Kidney | High dose → ADH-like effect → ↓ urine → water intoxication |
| CVS | High dose → vasodilation, hypotension → reflex tachycardia, flushing |
Mechanism:
- Binds to G-protein coupled receptor on myometrium
- → ↑ IP₃ → releases Ca²⁺ from intracellular stores
- → ↑ PG production by endometrium
- → Uterine contraction
Uses of Oxytocin — 4 main:
1. Induction of labour — Drug of choice
- Given by IV infusion
- Start low dose, monitor and adjust
- Monitor: uterine contractions, BP, fetal + maternal heart rate
2. Postpartum Haemorrhage (PPH) — prevention and treatment
- Contracts uterine muscle → compresses blood vessels → stops bleeding
- Preferred over ergot derivatives (fewer side effects)
- Given IM (prevention) or IV infusion (treatment)
3. Uterine inertia — IV infusion to strengthen weak contractions during labour
4. Breast engorgement — intranasal oxytocin → milk let-down (↑ milk ejection)
⚡ SUPER QUICK REVISION — ALL TOPICS
| Topic | 3 Most Important Points |
|---|
| Thyroid synthesis | NIS traps iodide → peroxidase oxidizes → coupling makes T3/T4 |
| Thioamides | Block peroxidase; PTU also blocks T4→T3; carbimazole preferred long-term |
| Radioactive iodine | ¹³¹I, half-life 8 days; elderly/cardiac patients; CI in pregnancy |
| Thyroid storm | Propranolol + PTU + Sodium ipodate + Hydrocortisone |
| Insulin | Tyrosine kinase receptor; SC route; hypoglycaemia = MC complication |
| DKA | Type 1 DM; IV regular insulin + NS; add 5% dextrose when BG ~250; KCl after 4 hrs |
| Sulphonylureas | K⁺-ATP channel blockers → ↑ insulin; hypoglycaemia MC; NOT in pregnancy |
| Metformin | AMPK activator; ↓ gluconeogenesis; no hypoglycaemia; lactic acidosis rare |
| Corticosteroids | Lipocortin inhibits phospholipase A₂; Cushing's, osteoporosis, peptic ulcer = ADR |
| Combined pill | ↓ FSH/LH (no ovulation); 21 days on, 7 off; 99% efficacy |
| Emergency pill | Levonorgestrel within 72 hrs OR mifepristone single dose |
| Tocolytics | β₂-agonists (ritodrine, salbutamol); indomethacin NOT used (closes ductus) |
| Oxytocin | Hypothalamus made; IP₃ → Ca²⁺ → contraction; DOC for induction of labour + PPH |
📌 Exam formula: Classification → Mechanism → Uses → Adverse Effects = full marks on any question